Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial

SUMMARY: BACKGROUND: Oral liarozole, a retinoic acid metabolism-blocking agent, may be an alternative to systemic retinoid therapy in patients with lamellar ichthyosis. OBJECTIVE: To demonstrate the efficacy and safety of once-daily oral liarozole in the treatment of moderate/severe lamellar ichthyo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vahlquist, A, Blockhuys, S, Steijlen, P, van Rossem, K, Didona, B, Blanco, D, Traupe, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232915/
https://www.ncbi.nlm.nih.gov/pubmed/24102348
http://dx.doi.org/10.1111/bjd.12626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232915/
https://www.ncbi.nlm.nih.gov/pubmed/24102348
http://dx.doi.org/10.1111/bjd.12626

Ejemplares similares